Human Gene Therapy Clinical Development
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Key Metrics
Journal Specifications
Indexed in the following public directories
CrossRef 
Scopus 
Web of Science
- PublisherMARY ANN LIEBERT, INC
- LanguageEnglish
- FrequencyQuarterly
- LanguageEnglish
- FrequencyQuarterly
- Publication Start Year2013
- Publisher URL
Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Human Gene Therapy Clinical Development been publishing? 
The Human Gene Therapy Clinical Development has been publishing since 2013 till date.
How frequently is the Human Gene Therapy Clinical Development published?
Human Gene Therapy Clinical Development is published Quarterly.
Who is the publisher of Human Gene Therapy Clinical Development?
The publisher of Human Gene Therapy Clinical Development is MARY ANN LIEBERT, INC.
How can I view the journal metrics of Human Gene Therapy Clinical Development on editage?
For the Human Gene Therapy Clinical Development metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Human Gene Therapy Clinical Development?
The eISSN number is 2324-8645 and pISSN number is 2324-8637 for Human Gene Therapy Clinical Development.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding Hunter syndrome, Clinical trial, Adeno-associated virus, Osteoarthritis, Neuroscience.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.